Short guideline - Cutaneous neuroendocrine carcinoma (Merkel cell carcinoma);Kurzleitlinie - Kutanes neuroendokrines Karzinom (Merkelzell-Karzinom)

JDDG - Journal of the German Society of Dermatology

Volumn 4, Issue 6, 2006, Pages 508-510

  Hauschild, Axel ^a   Garbe, Claus ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN ANTIBODY;

CANCER DIAGNOSIS; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MERKEL CELL TUMOR; METASTASIS; NEUROENDOCRINE DISEASE; PRACTICE GUIDELINE; PROGNOSIS; RISK FACTOR; SHORT SURVEY; SKIN CARCINOMA; ULTRASOUND;

CARCINOMA, MERKEL CELL; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 33745419247     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2006.05890.x     Document Type: Short Survey

References (1)

1. Hauschild A, Garbe C (2005) Deutsche Leitlinie: Merkelzellkarzinom (Kutanes neuroendokrines Karzinom). In: Garbe C (Hrsg.) Interdisziplinäre Leitlinien zur Diagnostik und Behandlung von Hauttumoren. Georg Thieme Verlag, Stuttgart, New York S. 56-61.